Need and prospects for prevention of cardiac failure

European Journal of Clinical Pharmacology

Volumn 49, Issue SUPPL. 1, 1996, Pages

  Kannel, W B ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

BLOOD PRESSURE; CONFERENCE PAPER; ELECTROCARDIOGRAM; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMAN; MALE; MORTALITY; PRIORITY JOURNAL; PROPHYLAXIS; RISK FACTOR; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 0030045142     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (15)

1. US Dept. of Health and Human Services (1994) NHLBI Report of the Task Force on Research in Heart Failure. PHS-NIH, Springfield, VA 22161
2. Kannel WB, HO K, Thom T (1994) The changing epidemiologic features of cardiac failure. Br Heart J 72 [Suppl 2]:S3-S9
3. Schocken DD, Arrieta MI, Leaverton PE (1992) Prevalence and mortality rate of congestive heart failure in the United States. JACC 20:301-306
4. National Heart, Lung and Blood Institute (1992) Morbidity and mortality chartbook on cardiovascular, lung and blood diseases, 1990. Bethesda
5. Graves EJ, National Center for Health Statistics (1991) Detailed diagnoses and procedures, National Hospital Discharge Survey, 1990. Vital and health statistics. Series 13, No. 113, DHHS Publ. No. (PHS) 92-1774, Springfield, VA 22161
6. Leavit KR, Lazcerby HC, Conan CA, Letscky SW (1991) National Heart Expenditures 1990. Health Care Financing Rev 13:29-54
7. Kannel WB, Cobb J (1992) Left ventricular hypertrophy and mortality-results from the Framingham Study. Cardiology 81:291-298
8. Kannel WB, Seidman JM, Fercho W, Castelli WP (1974) Vital capacity and congestive heart failure: the Framingham Study. Circulation 49:1160-1167
9. Pfeffer M (1991) Clinical implications of left ventricular hypertrophy in systemic hypertension. Cardiovasc Rev Rep:53-60
10. Levy D, Saloman M, D'Agostino R, Belanger AJ, Kannel WB (1994) Prognostic implications of baseline ECG features and their serial changes in subjects with left ventricular hypertrophy. Circulation 90:1786-1793
11. Strauer BE, Atef Mahmond M, Bayer F, Bohu I, Motz U (1984) Reversal of left ventricular hypertrophy and improvement of cardiac function in man by nifedipine. Eur Heart J [Suppl F]: 53-60
12. Schulman SP, Weiss JL, Becker LC, et al (1990) The effects of antihypertensive therapy on left ventricular mass in elderly patients. N Eng J Med 322:1350-1356
13. Gillman MW, Kannel WB, Belanger A, D'Agostino RB (1993) Influence of heart rate on mortality among persons with hypertension: the Framingham Study. Am Heart J 125:1148-1154
14. Kannel WB, Hjortland M, Castelli WP (1974) Role of diabetes in congestive heart failure. The Framingham Study. Am J Cardiol 34:29-34
15. SOLVD Investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Eng J Med 327:685-691